Control of breathing Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=44 Year: 2005
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea Source: Eur Respir J 2011; 37: 89-97 Year: 2011
Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4) 1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea Source: International Congress 2019 – State of the art session: Sleep and breathing disorders Year: 2019
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors Source: Eur Respir J 2003; 21: 977-984 Year: 2003
Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link Source: Eur Respir J 2010; 36: 143-150 Year: 2010
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Intermittent hypoxia in sleep apnea: a cause of inflammatory activation Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007
Relationship of oxidative stress and endothelial dysfunction in sleep apnoea Source: Eur Respir J 2011; 37: 873-879 Year: 2011
Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation Source: Eur Respir J 2001; 17: 848-855 Year: 2001
Mechanisms and assessment of vascular damage in obstructive sleep apnoea Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea” Year: 2013
Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea Source: Eur Respir J 2009; 34: 1390-1398 Year: 2009
Relationship between upper airway inflammation and systemic inflammation in obstructive sleep apnoea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
The influence of obesity and overweight on hypercapnic and hypoxic respiratory responses in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 183s Year: 2003
Upper airway and systemic inflammation in obstructive sleep apnoea Source: Eur Respir J 2016; 48: 1108-1117 Year: 2016